Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis

Turner, N; Strand, A; Grewal, DS; Cox, G; Arif, S; Baker, AW; Maziarz, EK; Saullo, JH; Wolfe, CR

Turner, N; Wolfe, CR (reprint author), Duke Univ, Sch Med, Div Infect Dis, Durham, NC 27708 USA.; Turner, N (reprint author), Duke Ctr Antimicrobial Stewardship & Infect Preve, Durham, NC 27708 USA.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019; 63 (3):

Abstract

Treatment options for drug-resistant cytomegalovirus (CMV) are limited. Letermovir is a novel antiviral recently approved for CMV prophylaxis followin......

Full Text Link